Signe Regner Michaelsen
Postdoc
Kristensen Group
Ole Maaløes Vej 5
2200 København N.
1 - 2 out of 2Page size: 10
- 2020
- Published
Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma
Urup, T., Gillberg, Linn, Kaastrup, K., Lü, M. J. S., Michaelsen, Signe Regner, Andrée Larsen, V., Christensen, I. J., Broholm, H., Lassen, Ulrik Niels, Grønbæk, Kirsten & Poulsen, H. S., 2020, In: Molecular Oncology. 14, 5, p. 964-973Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study
Nørøxe, D. S., Yde, C. W., Østrup, O., Michaelsen, Signe Regner, Schmidt, A. Y., Kinalis, S., Torp, M. H., Skjøth‐Rasmussen, J., Brennum, J., Hamerlik, P., Poulsen, H. S., Nielsen, Finn Cilius & Lassen, Ulrik Niels, 2020, In: Molecular Oncology.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 108812376
Most downloads
-
223
downloads
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
114
downloads
Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
102
downloads
Targeting glioma stem-like cell survival and chemoresistance through inhibition of lysine-specific histone demethylase KDM2B
Research output: Contribution to journal › Journal article › Research › peer-review
Published